363 related articles for article (PubMed ID: 24352601)
1. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program.
Jafari MD; Halabi WJ; Stamos MJ; Nguyen VQ; Carmichael JC; Mills SD; Pigazzi A
JAMA Surg; 2014 Feb; 149(2):170-5. PubMed ID: 24352601
[TBL] [Abstract][Full Text] [Related]
2. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.
Foster JM; Sleightholm R; Patel A; Shostrom V; Hall B; Neilsen B; Bartlett D; Smith L
JAMA Netw Open; 2019 Jan; 2(1):e186847. PubMed ID: 30646202
[TBL] [Abstract][Full Text] [Related]
4. Initial experience with hyperthermic intraperitoneal chemotherapy.
Turrini O; Lambaudie E; Faucher M; Viret F; Blache JL; Houvenaeghel G; Delpero JR
Arch Surg; 2012 Oct; 147(10):919-23. PubMed ID: 23117830
[TBL] [Abstract][Full Text] [Related]
5. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
Chua TC; Quinn LE; Zhao J; Morris DL
J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
[TBL] [Abstract][Full Text] [Related]
6. Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program.
Hinkle NM; MacDonald J; Sharpe JP; Dickson P; Deneve J; Munene G
Am J Surg; 2016 Sep; 212(3):413-8. PubMed ID: 27086201
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
Teo MC; Tan GH; Tham CK; Lim C; Soo KC
Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
[TBL] [Abstract][Full Text] [Related]
8. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center.
Gusani NJ; Cho SW; Colovos C; Seo S; Franko J; Richard SD; Edwards RP; Brown CK; Holtzman MP; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2008 Mar; 15(3):754-63. PubMed ID: 18080166
[TBL] [Abstract][Full Text] [Related]
9. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Iversen LH; Rasmussen PC; Laurberg S
Br J Surg; 2013 Jan; 100(2):285-92. PubMed ID: 23124619
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
[TBL] [Abstract][Full Text] [Related]
11. Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status.
Ihemelandu CU; McQuellon R; Shen P; Stewart JH; Votanopoulos K; Levine EA
Ann Surg Oncol; 2013 Oct; 20(11):3519-26. PubMed ID: 23748607
[TBL] [Abstract][Full Text] [Related]
12. Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Lyon TD; Turner Ii RM; Nikonow TN; Wang L; Uy J; Ramalingam L; Holtzman MP; Pingpank JF; Bartlett DL; Davies BJ
J Surg Oncol; 2016 Feb; 113(2):218-22. PubMed ID: 26775909
[TBL] [Abstract][Full Text] [Related]
13. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
Glockzin G; von Breitenbuch P; Schlitt HJ; Piso P
J Surg Oncol; 2013 May; 107(6):574-8. PubMed ID: 22833286
[TBL] [Abstract][Full Text] [Related]
14. Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study.
Leapman MS; Jibara G; Tabrizian P; Franssen B; Yang MJ; Romanoff A; Hall SJ; Palese M; Sarpel U; Hiotis S; Labow D
Ann Surg Oncol; 2014 Apr; 21(4):1153-8. PubMed ID: 24322531
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients.
Macrì A; Saladino E; Trimarchi G; Bartolo V; Rossitto M; Cannaò A; Rizzo A; Famulari C
In Vivo; 2011; 25(4):687-90. PubMed ID: 21709015
[TBL] [Abstract][Full Text] [Related]
16. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in peritoneal carcinomatosis: a prospective study in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Albertsmeier M; Hauer A; Niess H; Werner J; Graeb C; Angele MK
Dig Surg; 2014; 31(4-5):334-40. PubMed ID: 25471828
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience.
Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2013 Dec; 68(6):569-77. PubMed ID: 24193289
[TBL] [Abstract][Full Text] [Related]
19. Failure to rescue following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Li KY; Mokdad AA; Minter RM; Mansour JC; Choti MA; Augustine MM; Polanco PM
J Surg Res; 2017 Jun; 214():209-215. PubMed ID: 28624046
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
